21.09
price down icon6.39%   -1.44
after-market Handel nachbörslich: 21.09
loading

Finanzdaten der Anaptysbio Inc-Aktie (ANAB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
19.83%
22.26
27.77 30.02 10.97 7.179
Operating Expenses
12.43%
48.43
55.31 52.77 51.29 49.38
Benefits Costs and Expenses
9.25%
60.85
67.06 62.87 57.62 -
Costs And Expenses
9.25%
60.85
67.06 62.87 57.62 49.38
Operating Income/Loss
4.97%
-26.17
-27.54 -22.76 -40.32 -42.20
Nonoperating Income/Loss
5.75%
-12.42
-11.75 -10.09 -6.33 -1.735
Income/Loss From Continuing Operations Before Tax
1.77%
-38.59
-39.28 -32.85 -46.65 -43.94
Income Tax Expense/Benefit
11.36%
0.039
0.044 - 0.009 -
Income/Loss From Continuing Operations After Tax
1.78%
-38.63
-39.33 -32.85 -46.66 -43.94
Net Income/Loss
1.78%
-38.63
-39.33 -32.85 -46.66 -43.94
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5.98%
28.81
30.64 28.89 27.36 26.80
Diluted Average Shares
5.98%
28.81
30.64 28.89 27.36 26.80
Basic Earnings Per Share
4.69%
-1.34
-1.28 -1.14 -1.71 -1.64
Diluted Earnings Per Share
4.69%
-1.34
-1.28 -1.14 -1.71 -1.64
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):